Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lin, Tzu Yu ^a,c   Lin, Yu Wan ^b   Lu, Cheng Wei ^a,c   Huang, Shu Kuei ^a   Wang, Su Jane ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYASPARTIC ACID; 4 AMINOPYRIDINE; BAFILOMYCIN A1; BERBERINE; CALCIUM CHANNEL; CALCIUM CHANNEL CAV2.1; CALCIUM ION; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SYNAPSIN I; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 2; CALCIUM; FAMPRIDINE;

AMINO ACID ANALYSIS; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENZYME PHOSPHORYLATION; EVOKED CORTICAL RESPONSE; EXTRACELLULAR CALCIUM; IC 50; MALE; MOLECULAR DYNAMICS; NERVE ENDING; NERVE EXCITABILITY; NONHUMAN; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; MAPK SIGNALING; MEMBRANE POTENTIAL; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

MUS; RATTUS;

4-AMINOPYRIDINE; ANIMALS; BERBERINE; CALCIUM; CEREBRAL CORTEX; GLUTAMIC ACID; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIALS; NERVE ENDINGS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 84879213203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067215     Document Type: Article

References (51)

1. Kulkarni SK, Dhir A, (2010) Berberine:a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24: 317-324.
2. Imanshahidi M, Hosseinzadeh H, (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22: 999-1012.
3. Ye M, Fu S, Pi R, He F, (2009) Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol 61: 831-837.
4. Yoo KY, Hwang IK, Lim BO, Kang TC, Kim DW, et al. (2006) Berberry extract reduces neuronal damage and N-methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol Pharm Bull 29: 623-628.
5. Zhou XQ, Zeng XN, Kong H, Sun XL, (2008) Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci Lett 447: 31-36.
6. Wang J, Zhang Y, Du S, Zhang M, (2011) Protective effects of berberine against amyloid beta-induced toxicity in cultured rat cortical neurons. Neural Regen Res 6: 183-187.
7. Hong JS, Chu YK, Lee H, Ahn BH, Park JH, et al. (2012) Effects of berberine on hippocampal neuronal damage and matrix metalloproteinase-9 activity following transient global cerebral ischemia. J Neurosci Res 90: 489-497.
8. Zhu F, Qian C, (2006) Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 7: 78.
9. Durairajan SS, Liu LF, Lu JH, Chen LL, Yuan Q, et al. (2012) Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiol Aging 33: 2903-2919.
10. Greenamyre JT, Porter RH, (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44: S7-13.
11. Coyle JT, Puttfarcken P, (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
12. Obrenovitch TP, Urenjak J, (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 51: 39-87.
13. Meldrum BS, (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130: 1007S-1015S.
14. Lin TY, Lu CW, Tien LT, Chuang SH, Wang YR, et al. (2009) Fangchinoline inhibits glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neurochem Int 54: 506-512.
15. Yi Chang Y, Wang SJ, (2010) Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway1. Eur J Pharmacol 634: 53-61.
16. Lin TY, Lu CW, Wang CC, Wang YC, Wang SJ, (2011) Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: Possible relevance to its antidepressant mechanism. Prog Neuropsychopharmacol Biol Psychiatry 35: 1785-1793.
17. Lin TY, Lu CW, Huang SK, Wang SJ, (2013) Tanshinone IIA, a consitutent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Ethnopharmacol 147: 488-496.
18. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA, (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372: 115-129.
19. Grewal SS, York RD, Stork PJ, (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9: 544-553.
20. Pereira DB, Carvalho AP, Duarte CB, (2002) Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes. Neuropharmacology 42: 9-19.
21. Lin TY, Lu CW, Wang CC, Lu JF, Wang SJ, (2012) Hispidulin inhibits the release of glutamate in rat cerebrocortical nerve terminals. Toxicol Appl Pharmacol 263: 233-243.
22. Yang TT, Wang SJ, (2009) Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism? J Pharmacol Exp Ther 331: 244-254.
23. Lu CW, Lin TY, Wang CC, Wang SJ, (2012) Sigma-1 receptor agonist, SKF10047, inhibits glutamate release in rat cerebral cortex nerve endings. J Pharmacol Exp Ther 341: 532-542.
24. McMahon HT, Nicholls DG, (1991) The bioenergetics of neurotransmitter release. Biochim Biophys Acta 1059: 243-264.
25. Tibbs GR, Barrie AP, Van Mieghem FJ, McMahon HT, Nicholls DG, (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53: 1693-1699.
26. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS, (1991) An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 57: 1398-1404.
27. Nicholls DG, (1998) Presynaptic modulation of glutamate release. Prog Brain Res 116: 15-22.
28. Akerman KE, Scott IG, Heikkila JE, Heinonen E, (1987) Ionic dependence of membrane potential and glutamate receptor-linked responses in synaptoneurosomes as measured with a cyanine dye, DiSC2(5). J Neurochem 48: 552-559.
29. Sihra TS, Bogonez E, Nicholls DG, (1992) Localized Ca2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267: 1983-1989.
30. Grynkiewicz G, Poenie M, Tsien RY, (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
31. Nicholls DG, Sihra TS, Sanchez-Prieto J, (1987) Calcium-dependent and-independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 49: 50-57.
32. Vazquez E, Sanchez-Prieto J, (1997) Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur J Neurosci 9: 2009-2018.
33. Millan C, Sanchez-Prieto J, (2002) Differential coupling of N- and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex. Neurosci Lett 330: 29-32.
34. Regan LJ, Sah DW, Bean BP, (1991) Ca2+ channels in rat central and peripheral neurons: high-threshold current resistant to dihydropyridine blockers and omega-conotoxin. Neuron 6: 269-280.
35. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, et al. (1992) P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355: 827-829.
36. Berridge MJ, (1998) Neuronal calcium signaling. Neuron 21: 13-26.
37. Rehm H, Tempel BL, (1991) Voltage-gated K+ channels of mammalian brain. FASEB J 5: 164-170.
38. Li M, West JW, Numann R, Murphy BJ, Scheuer T, et al. (1993) Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science 261: 1439-1442.
39. Pongs O, Leicher T, Berger M, Roeper J, Bahring R, et al. (1999) Functional and molecular aspects of voltage-gated K+ channel beta subunits. Ann N Y Acad Sci 868: 344-355.
40. Wang F, Zhao G, Cheng L, Zhou HY, Fu LY, et al. (2004) Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res 999: 91-97.
41. Jovanovic JN, Benfenati F, Siow YL, Sihra TS, Sanghera JS, et al. (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A 93: 3679-3683.
42. Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS, (2000) Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 3: 323-329.
43. Yamagata Y, Jovanovic JN, Czernik AJ, Greengard P, Obata K, (2002) Bidirectional changes in synapsin I phosphorylation at MAP kinase-dependent sites by acute neuronal excitation in vivo. J Neurochem 80: 835-842.
44. Chi P, Greengard P, Ryan TA, (2003) Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 38: 69-78.
45. Fdez E, Hilfiker S, (2006) Vesicle pools and synapsins: new insights into old enigmas. Brain Cell Biol 35: 107-115.
46. Wang X, Wang R, Xing D, Su H, Ma C, et al. (2005) Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 77: 3058-3067.
47. Zhu F, Wu F, Ma Y, Liu G, Li Z, et al. (2011) Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells. BMC Neurosci 12: 125.
48. Niebroj-Dobosz I, Janik P, Kwiecinski H, (2002) Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 106: 39-43.
49. Wang SJ, Wang KY, Wang WC, (2004) Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 125: 191-201.
50. Mdzinarishvili A, Sumbria R, Lang D, Klein J, (2012) Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. J Pharm Pharm Sci 15: 94-102.
51. Cui HS, Matsumoto K, Murakami Y, Hori H, Zhao Q, et al. (2009) Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression. Biol Pharm Bull 32: 79-85.